{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T15:12:53Z","timestamp":1788361973430,"version":"build-2803163510"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100005716","name":"Babol University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005716","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infection, Genetics and Evolution"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/j.meegid.2018.01.015","type":"journal-article","created":{"date-parts":[[2018,2,4]],"date-time":"2018-02-04T06:44:57Z","timestamp":1517726697000},"page":"32-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["The role of regulatory T cells in immunopathogenesis and immunotherapy of viral infections"],"prefix":"10.1016","volume":"59","author":[{"given":"Ahmad","family":"Karkhah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mostafa","family":"Javanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soheil","family":"Ebrahimpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.meegid.2018.01.015_bb0005","doi-asserted-by":"crossref","first-page":"5882","DOI":"10.1128\/JVI.02202-06","article-title":"Hepatitis C virus (HCV)-specific CD8+ cells produce transforming growth factor \u03b2 that can suppress HCV-specific T-cell responses","volume":"81","author":"Alatrakchi","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0010","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11882-016-0606-9","article-title":"T regulatory cell biology in health and disease","volume":"16","author":"Alroqi","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.meegid.2018.01.015_bb0015","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1038\/mt.2012.71","article-title":"Enforced IL-10 expression confers type 1 regulatory T cell (Tr1) phenotype and function to human CD4(+) T cells","volume":"20","author":"Andolfi","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.meegid.2018.01.015_bb0020","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1084\/jem.184.2.387","article-title":"Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation","volume":"184","author":"Asano","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.meegid.2018.01.015_bb0025","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1365-2249.2007.03521.x","article-title":"Increase of CD4+ CD25+ regulatory T cells in the peripheral blood of patients with metastatic carcinoma: a phase I clinical trial using cyclophosphamide and immunotherapy to eliminate CD4+ CD25+ T lymphocytes","volume":"150","author":"Audia","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0030","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.dld.2015.06.014","article-title":"Role of regulatory T-cells during hepatitis C infection: from the acute phase to post-transplantation recurrence","volume":"47","author":"Barjon","year":"2015","journal-title":"Dig. Liver Dis."},{"key":"10.1016\/j.meegid.2018.01.015_bb0035","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/sj.jid.5700004","article-title":"Regulatory T cells","volume":"126","author":"Beissert","year":"2006","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0040","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/ni1181","article-title":"Natural regulatory T cells in infectious disease","volume":"6","author":"Belkaid","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0045","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature04753","article-title":"Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells","volume":"441","author":"Bettelli","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.meegid.2018.01.015_bb0050","doi-asserted-by":"crossref","first-page":"4858","DOI":"10.3748\/wjg.v13.i36.4858","article-title":"Regulatory T cells in viral hepatitis","volume":"13","author":"Billerbeck","year":"2007","journal-title":"World J Gastroenterol: WJG"},{"key":"10.1016\/j.meegid.2018.01.015_bb0055","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1002\/eji.200324251","article-title":"Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes","volume":"33","author":"Brady","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0060","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12865-015-0075-2","article-title":"New challenges in modern vaccinology","volume":"16","author":"Centlivre","year":"2015","journal-title":"BMC Immunol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0065","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2217\/imt.11.79","article-title":"Tregs in immunotherapy: opportunities and challenges","volume":"3","author":"Chen","year":"2011","journal-title":"Immunotherapy"},{"key":"10.1016\/j.meegid.2018.01.015_bb0070","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3389\/fimmu.2014.00590","article-title":"Metabolic regulation of regulatory T cell development and function","volume":"5","author":"Coe","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0075","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI31202","article-title":"Tregs and rethinking cancer immunotherapy","volume":"117","author":"Curiel","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.meegid.2018.01.015_bb0080","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12974-017-0892-8","article-title":"Regulatory T cells in multiple sclerosis and myasthenia gravis","volume":"14","author":"Danikowski","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.meegid.2018.01.015_bb0085","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1172\/JCI25947","article-title":"Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells","volume":"115","author":"Dannull","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.meegid.2018.01.015_bb0090","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1016\/S0264-410X(01)00145-1","article-title":"From genome to vaccine: in silico predictions, ex vivo verification","volume":"19","author":"De Groot","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.meegid.2018.01.015_bb0095","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1189\/jlb.1107770","article-title":"T cells with regulatory activity in hepatitis C virus infection: what we know and what we don't","volume":"84","author":"Dolganiuc","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0100","doi-asserted-by":"crossref","first-page":"5043","DOI":"10.1128\/JVI.01548-07","article-title":"Identification and in vitro expansion of functional antigen-specific CD25+ FoxP3+ regulatory T cells in hepatitis C virus infection","volume":"82","author":"Ebinuma","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0105","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0110","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1084\/jem.20050784","article-title":"Developmental regulation of Foxp3 expression during ontogeny","volume":"202","author":"Fontenot","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.meegid.2018.01.015_bb0115","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0065-2776(10)05004-2","article-title":"The family of IL-10-secreting CD4+ T cells","volume":"105","author":"Fujio","year":"2010","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0120","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nature05543","article-title":"Foxp3-dependent programme of regulatory T-cell differentiation","volume":"445","author":"Gavin","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.meegid.2018.01.015_bb0125","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.smim.2003.12.004","article-title":"Role of dendritic cells in the generation of regulatory T cells","volume":"16","author":"Groux","year":"2004","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0130","first-page":"675","article-title":"Evaluation of CD4+ CD25+ FoxP3+ regulatory T cells during treatment of patients with brucellosis","volume":"30","author":"Hasanjani","year":"2016","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.meegid.2018.01.015_bb0135","doi-asserted-by":"crossref","first-page":"12542","DOI":"10.1073\/pnas.1715363114","article-title":"Metabolic control of regulatory T cell (Treg) survival and function by Lkb1","volume":"114","author":"He","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.meegid.2018.01.015_bb0140","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1002\/eji.200737966","article-title":"Circumvention of regulatory CD4(+) T cell activity during cross-priming strongly enhances T cell-mediated immunity","volume":"38","author":"Heit","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0145","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.meegid.2018.01.015_bb0150","doi-asserted-by":"crossref","first-page":"330","DOI":"10.4110\/in.2016.16.6.330","article-title":"Regulatory T cells in hepatitis B and C virus infections","volume":"16","author":"Jung","year":"2016","journal-title":"Immune Netw."},{"key":"10.1016\/j.meegid.2018.01.015_bb0155","series-title":"A Potent Multivalent Vaccine for Modulation of Immune System in Atherosclerosis: an In Silico Approach","first-page":"50","volume":"5","author":"Karkhah","year":"2016"},{"key":"10.1016\/j.meegid.2018.01.015_bb0160","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.compbiolchem.2017.01.011","article-title":"In silico analyses of heat shock protein 60 and calreticulin to designing a novel vaccine shifting immune response toward T helper 2 in atherosclerosis","volume":"67","author":"Karkhah","year":"2017","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.meegid.2018.01.015_bb0165","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.4049\/jimmunol.1101649","article-title":"Regulatory T cells selectively control CD8+ T cell effector pool size via IL-2 restriction","volume":"187","author":"Kastenmuller","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0170","doi-asserted-by":"crossref","first-page":"6947","DOI":"10.1158\/1078-0432.CCR-07-0842","article-title":"CD8+ Foxp3+ regulatory T cells mediate immunosuppression in prostate cancer","volume":"13","author":"Kiniwa","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.meegid.2018.01.015_bb0175","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0180","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000067596","article-title":"The role of IL-10 and TGF-beta in the differentiation and effector function of T regulatory cells","volume":"129","author":"Levings","year":"2002","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0185","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1002\/eji.201041093","article-title":"Efficient Treg depletion induces T-cell infiltration and rejection of large tumors","volume":"40","author":"Li","year":"2010","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0190","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cdtm.2016.09.001","article-title":"Regulatory T-cells promote hepatitis B virus infection and hepatocellular carcinoma progression","volume":"2","author":"Li","year":"2016","journal-title":"Chronic Dis. Transl. Med."},{"key":"10.1016\/j.meegid.2018.01.015_bb0195","doi-asserted-by":"crossref","first-page":"192","DOI":"10.3389\/fimmu.2016.00192","article-title":"Functional mechanisms of Treg in the context of HIV infection and the Janus face of immune suppression","volume":"7","author":"Lopez-Abente","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0200","first-page":"153","article-title":"Causal role of infectious agents in cancer: an overview","volume":"8","author":"Masrour-Roudsari","year":"2017","journal-title":"Caspian J. Intern. Med."},{"key":"10.1016\/j.meegid.2018.01.015_bb0205","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jconrel.2015.07.029","article-title":"Single-injection vaccines: progress, challenges, and opportunities","volume":"219","author":"McHugh","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.meegid.2018.01.015_bb0210","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/nri1485","article-title":"Regulatory T cells: friend or foe in immunity to infection?","volume":"4","author":"Mills","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0215","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/eji.200324578","article-title":"Mini-review: regulatory T cells and infection: suppression revisited","volume":"34","author":"Mittrucker","year":"2004","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0220","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1601-0825.2007.01419.x","article-title":"Hepatitis C: a clinical review","volume":"14","author":"Modi","year":"2008","journal-title":"Oral Dis."},{"key":"10.1016\/j.meegid.2018.01.015_bb0225","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5539\/jmbr.v7n1p9","article-title":"Regulatory T-cell: regulator of host defense in infection","volume":"7","author":"Mohammadnia-Afrouzi","year":"2017","journal-title":"J. Mol. Biol. Res."},{"key":"10.1016\/j.meegid.2018.01.015_bb0230","doi-asserted-by":"crossref","first-page":"502","DOI":"10.3389\/fmicb.2014.00502","article-title":"Smarter vaccine design will circumvent regulatory T cell-mediated evasion in chronic HIV and HCV infection","volume":"5","author":"Moise","year":"2014","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0235","doi-asserted-by":"crossref","first-page":"12925","DOI":"10.1128\/JVI.01352-09","article-title":"Human regulatory T cells are targets for human immunodeficiency virus (HIV) infection, and their susceptibility differs depending on the HIV type 1 strain","volume":"83","author":"Moreno-Fernandez","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0240","doi-asserted-by":"crossref","first-page":"5372","DOI":"10.1182\/blood-2010-12-323162","article-title":"Regulatory T cells control HIV replication in activated T cells through a cAMP-dependent mechanism","volume":"117","author":"Moreno-Fernandez","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.meegid.2018.01.015_bb0245","doi-asserted-by":"crossref","first-page":"10262","DOI":"10.1128\/JVI.00993-12","article-title":"Homeostasis and function of regulatory T cells in HIV\/SIV infection","volume":"86","author":"Moreno-Fernandez","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0250","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/cgt.2011.63","article-title":"Depleting regulatory T cells with arginine-rich, cell-penetrating, peptide-conjugated morpholino oligomer targeting FOXP3 inhibits regulatory T-cell function","volume":"19","author":"Morse","year":"2012","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.meegid.2018.01.015_bb0255","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1189\/jlb.0507281","article-title":"FOXP3 expressing CD127lo CD4+ T cells inversely correlate with CD38+ CD8+ T cell activation levels in primary HIV-1 infection","volume":"83","author":"Ndhlovu","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0260","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/rheumatology\/kep028","article-title":"Th17 and regulatory T cells: rebalancing pro- and anti-inflammatory forces in autoimmune arthritis","volume":"48","author":"Nistala","year":"2009","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.meegid.2018.01.015_bb0265","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mhpa.2016.12.002","article-title":"Acute effects of resistance exercise in a depressed HIV sample: the exercise for people who are immunocompromised (EPIC) study","volume":"12","author":"Nosrat","year":"2017","journal-title":"Ment. Health and Phys. Act."},{"key":"10.1016\/j.meegid.2018.01.015_bb0270","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1002\/eji.201041387","article-title":"The adjuvant effect of TLR agonists on CD4(+) effector T cells is under the indirect control of regulatory T cells","volume":"41","author":"Olivier","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0275","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1086\/523651","article-title":"Functional suppression by FoxP3+CD4+CD25high regulatory T cells during acute hepatitis C virus infection","volume":"197","author":"Pearson","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.meegid.2018.01.015_bb0280","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1172\/JCI200423595","article-title":"Tregs and allergic disease","volume":"114","author":"Robinson","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.meegid.2018.01.015_bb0285","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.0105-2896.2006.00420.x","article-title":"Interleukin-10-secreting type 1 regulatory T cells in rodents and humans","volume":"212","author":"Roncarolo","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.meegid.2018.01.015_bb0290","doi-asserted-by":"crossref","first-page":"7852","DOI":"10.1128\/JVI.79.12.7852-7859.2005","article-title":"Regulatory T cells suppress in vitro proliferation of virus-specific CD8+ T cells during persistent hepatitis C virus infection","volume":"79","author":"Rushbrook","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0295","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.meegid.2017.04.009","article-title":"Development of a multi-epitope peptide vaccine inducing robust T cell responses against brucellosis using immunoinformatics based approaches","volume":"51","author":"Saadi","year":"2017","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0300","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/ni1178","article-title":"Naturally arising Foxp3-expressing CD25+ CD4+ regulatory T cells in immunological tolerance to self and non-self","volume":"6","author":"Sakaguchi","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0305","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0310","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.0105-2896.2006.00427.x","article-title":"Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease","volume":"212","author":"Sakaguchi","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.meegid.2018.01.015_bb0315","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri2274","article-title":"T-cell quality in memory and protection: implications for vaccine design","volume":"8","author":"Seder","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0320","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.0105-2896.2006.00415.x","article-title":"The lifestyle of naturally occurring CD4+ CD25+ Foxp3+ regulatory T cells","volume":"212","author":"Shevach","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.meegid.2018.01.015_bb0325","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1084\/jem.20110278","article-title":"HIF1\u03b1\u2013dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells","volume":"208","author":"Shi","year":"2011","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.meegid.2018.01.015_bb0330","doi-asserted-by":"crossref","first-page":"215","DOI":"10.3389\/fimmu.2013.00215","article-title":"CD4+FOXP3+ regulatory T-cell subsets in human immunodeficiency virus infection","volume":"4","author":"Simonetta","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0335","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2013.00215","article-title":"CD4+ FOXP3+ regulatory T-cell subsets in human immunodeficiency virus infection","volume":"4","author":"Simonetta","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0340","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00281-011-0245-0","article-title":"Immunomodulatory effects of cyclophosphamide and implementations for vaccine design","volume":"33","author":"Sistigu","year":"2011","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0345","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.it.2008.04.002","article-title":"Revival of CD8+ Treg-mediated suppression","volume":"29","author":"Smith","year":"2008","journal-title":"Trends Immunol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0350","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/hep.20649","article-title":"Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection","volume":"41","author":"Stoop","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.meegid.2018.01.015_bb0355","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/cr.2016.151","article-title":"Regulatory T cells in cancer immunotherapy","volume":"27","author":"Tanaka","year":"2017","journal-title":"Cell Res."},{"key":"10.1016\/j.meegid.2018.01.015_bb0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2009.11.009","article-title":"Epidemiology of hepatitis B and C viruses: a global overview","volume":"14","author":"Te","year":"2010","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.meegid.2018.01.015_bb0365","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/QAI.0b013e31817bbea5","article-title":"The relationship of T-regulatory cell subsets to disease stage, immune activation, and pathogen-specific immunity in HIV infection","volume":"48","author":"Tenorio","year":"2008","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.meegid.2018.01.015_bb0370","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.2217\/fvl.12.108","article-title":"Role of T-cell epitope-based vaccine in prophylactic and therapeutic applications","volume":"7","author":"Testa","year":"2012","journal-title":"Futur. Virol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0375","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.compbiolchem.2017.08.016","article-title":"Development of an epitope-based vaccine inhibiting immune cells rolling and migration against atherosclerosis using in silico approaches","volume":"70","author":"Tourani","year":"2017","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.meegid.2018.01.015_bb0380","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s10875-011-9509-7","article-title":"Circulating Tregs correlate with viral load reduction in chronic HBV-treated patients with tenofovir disoproxil fumarate","volume":"31","author":"Trehanpati","year":"2011","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0385","first-page":"700","article-title":"Immunological mechanisms of hepatitis B virus persistence in newborns","volume":"138","author":"Trehanpati","year":"2013","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.meegid.2018.01.015_bb0390","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1002\/eji.200738114","article-title":"How many mechanisms do regulatory T cells need?","volume":"38","author":"Vignali","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0395","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrd3683","article-title":"Therapeutic opportunities for manipulating T(Reg) cells in autoimmunity and cancer","volume":"12","author":"Von Boehmer","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.meegid.2018.01.015_bb0400","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1600-065X.2007.00565.x","article-title":"'Yin-Yang' functions of transforming growth factor-beta and T regulatory cells in immune regulation","volume":"220","author":"Wan","year":"2007","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.meegid.2018.01.015_bb0405","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10875-008-9251-y","article-title":"TGF-beta and regulatory T cell in immunity and autoimmunity","volume":"28","author":"Wan","year":"2008","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0410","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1128\/JVI.01758-10","article-title":"Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease","volume":"85","author":"Wiesch","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2018.01.015_bb5000","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1440-1746.2011.06940.x","article-title":"Immunopathogenesis and prognostic immune markers of chronic hepatitis B virus infection","volume":"27","author":"Zhang","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.meegid.2018.01.015_bb0415","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nri1806","article-title":"Regulatory T cells, tumour immunity and immunotherapy","volume":"6","author":"Zou","year":"2006","journal-title":"Nat. Rev. Immunol."}],"container-title":["Infection, Genetics and Evolution"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134818300157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134818300157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T23:28:31Z","timestamp":1719790111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567134818300157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4]]},"references-count":84,"alternative-id":["S1567134818300157"],"URL":"https:\/\/doi.org\/10.1016\/j.meegid.2018.01.015","relation":{},"ISSN":["1567-1348"],"issn-type":[{"value":"1567-1348","type":"print"}],"subject":[],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of regulatory T cells in immunopathogenesis and immunotherapy of viral infections","name":"articletitle","label":"Article Title"},{"value":"Infection, Genetics and Evolution","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.meegid.2018.01.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}